Dieterle F - Search Results

1

Metabolomic serum abnormalities in dogs with hepatopathies.

Imbery CA, Dieterle F, Ottka C, Weber C, Schlotterbeck G, Müller E, Lohi H, Giger U. Imbery CA, et al. Among authors: dieterle f. Sci Rep. 2022 Mar 29;12(1):5329. doi: 10.1038/s41598-022-09056-5. Sci Rep. 2022. PMID: 35351920 Free PMC article.

2

Metabolomic Abnormalities in Serum from Untreated and Treated Dogs with Hyper- and Hypoadrenocorticism.

Imbery CA, Dieterle F, Ottka C, Weber C, Schlotterbeck G, Müller E, Lohi H, Giger U. Imbery CA, et al. Among authors: dieterle f. Metabolites. 2022 Apr 9;12(4):339. doi: 10.3390/metabo12040339. Metabolites. 2022. PMID: 35448526 Free PMC article.

3

NMR and MS Methods for Metabolomics.

Amberg A, Riefke B, Schlotterbeck G, Ross A, Senn H, Dieterle F, Keck M. Amberg A, et al. Among authors: dieterle f. Methods Mol Biol. 2017;1641:229-258. doi: 10.1007/978-1-4939-7172-5_13. Methods Mol Biol. 2017. PMID: 28748468

4

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.

Schlotterbeck G, Ross A, Dieterle F, Senn H. Schlotterbeck G, et al. Among authors: dieterle f. Pharmacogenomics. 2006 Oct;7(7):1055-75. doi: 10.2217/14622416.7.7.1055. Pharmacogenomics. 2006. PMID: 17054416 Review.

5

Metabolite projection analysis for fast identification of metabolites in metabonomics. Application in an amiodarone study.

Dieterle F, Ross A, Schlotterbeck G, Senn H. Dieterle F, et al. Anal Chem. 2006 Jun 1;78(11):3551-61. doi: 10.1021/ac0518351. Anal Chem. 2006. PMID: 16737207

6

Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.

Dieterle F, Ross A, Schlotterbeck G, Senn H. Dieterle F, et al. Anal Chem. 2006 Jul 1;78(13):4281-90. doi: 10.1021/ac051632c. Anal Chem. 2006. PMID: 16808434

7

NMR and MS methods for metabonomics.

Dieterle F, Riefke B, Schlotterbeck G, Ross A, Senn H, Amberg A. Dieterle F, et al. Methods Mol Biol. 2011;691:385-415. doi: 10.1007/978-1-60761-849-2_24. Methods Mol Biol. 2011. PMID: 20972767

8

Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates.

Dieterle F, Schlotterbeck G, Binder M, Ross A, Suter L, Senn H. Dieterle F, et al. Chem Res Toxicol. 2007 Sep;20(9):1291-9. doi: 10.1021/tx700151t. Epub 2007 Aug 4. Chem Res Toxicol. 2007. PMID: 17676813

9

Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine.

Dieterle F, Schlotterbeck G, Ross A, Niederhauser U, Senn H. Dieterle F, et al. Chem Res Toxicol. 2006 Sep;19(9):1175-81. doi: 10.1021/tx060094b. Chem Res Toxicol. 2006. PMID: 16978021

10

Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers.

Matheis KA, Com E, Gautier JC, Guerreiro N, Brandenburg A, Gmuender H, Sposny A, Hewitt P, Amberg A, Boernsen O, Riefke B, Hoffmann D, Mally A, Kalkuhl A, Suter L, Dieterle F, Staedtler F. Matheis KA, et al. Among authors: dieterle f. Toxicol Appl Pharmacol. 2011 Apr 15;252(2):112-22. doi: 10.1016/j.taap.2010.11.006. Epub 2010 Nov 21. Toxicol Appl Pharmacol. 2011. PMID: 21081137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page